Xspray Pharma investor relations material
Listen to the latest call from Xspray Pharma
Xspray Pharma AB is a pharmaceutical company, which engages in the development of protein kinase inhibitors for targeted cancer treatments. Its product candidates include HyNap-Nilo and HyNap-DS. The company was founded by Lars Holmkvist, Ola Winqvist and Magnus Persson on April 3, 2003 and is headquartered in Solna, Sweden.